Healthcare Industry News: vascular closure
News Release - October 23, 2007
OmniSonics Appoints Sean McNerney as Vice President, SalesWILMINGTON, Mass., Oct. 23 (HSMN NewsFeed) -- OmniSonics Medical Technologies, Inc., a developer of advanced medical devices for use in the treatment of vascular disease, today announced the appointment of Sean M. McNerney to the position of Vice President, Sales.
Mr. McNerney comes to OmniSonics with over 15 years of experience building high-performance sales teams in the medical device market. His most recent position was with Datascope Corporation, where, as Vice President of Sales for the Interventional Products Division, he led a sales force focused on vascular closure products for interventional cardiology and radiology. He also served as the Vice President of Sales for Datascope's InterVascular Division, where he managed a direct sales force as well as distributors in North and South America to promote implantable grafts for vascular and cardiovascular surgery. Mr. McNerney previously held sales and marketing positions at U.S. Surgical, a division of Tyco Healthcare, including Marketing Director for the Suture Division and Regional Sales Director for the New England region. His experience includes launching, promoting, and selling capital and disposable equipment for a broad range of surgical specialties including gynecology, urology, thoracic, vascular, cardiovascular, plastic and general surgery.
"We're thrilled to have Sean join the management team at OmniSonics, and I'm confident that he will be able to make a major contribution to our commercialization plans," said Richard Ganz, president and chief executive officer of OmniSonics. "Having recently received 510K clearance for our OmniWave Endovascular System for treating thrombus in the peripheral vasculature, Sean's sales experience in the medical device field is exactly what we need to help build a successful sales organization for the company."
"This is the perfect time to join OmniSonics," said Mr. McNerney. "The company is ramping up its commercialization plans and preparing for a market launch of what I believe will be exciting new technology that can help improve the lives of patients with peripheral vascular disease. I'm looking forward to being part of the OmniSonics team."
About OmniSonics Medical Technologies, Inc.
OmniSonics Medical Technologies, Inc., based in Wilmington, MA, is a venture-backed medical device company focused on developing breakthrough products for the treatment of vascular disease. The Company's products are based on its patented OmniWave(TM) Technology, the first technology capable of delivering low-power ultrasonic energy around the active length of a small diameter wire in a diseased blood vessel. OmniWave Technology is designed to have broad applications in vascular disease. See http://www.omnisonics.com.
Source: OmniSonics Medical Technologies
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.